Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
CA 2448348 C · Owner: Nymox Corporation · Inventors: Averback, Paul A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient such as , benign and malignant tumors, using peptides derived from the amino acid sequences of neural thread proteins and related molecules.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 24, 2002 and granted July 16, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.